Related Scientific Literature
- Evaluation of antibody testing for SARS-Cov-2 using ELISA and lateral flow immunoassays
- Evaluation of nine commercial SARS-CoV-2 immunoassays
- Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients
- Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2
- Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis
- Reliability of serological tests for COVID-19: Comparison of three immunochromatography test kits for SARS-CoV-2 antibodies
- Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2
- Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study
- Qualitative assessment of SARS-CoV-2-specific antibody avidity by lateral flow immunochromatographic IgG/IgM antibody assay
- Immunological assays for SARS-CoV-2: an analysis of available commercial tests to measure antigen and antibodies
- COVID-19 Serological Tests: How Well Do They Actually Perform?
- In vitro diagnostics of coronavirus disease 2019: Technologies and application
- SARS-CoV-2 infection serology: a useful tool to overcome lockdown?
- Antibody tests in detecting SARS-CoV-2 infection: A meta-analysis
- Diagnostic performance of serological assays in the detection of SARS-CoV-2: A review
- Assay Techniques and Test Development for COVID-19 Diagnosis.
- Comparison of various serological assays for novel SARS-COV-2
- Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020